Gene therapy for Duchenne muscular dystrophy — the delivery of functional micro-dystrophin genes using adeno-associated virus (AAV) vectors to skeletal and cardiac muscle throughout the body, aiming to restore partial dystrophin protein function and halt or reverse the progressive muscle degeneration that characterizes DMD — representing the most transformative therapeutic ambition...